Paul Tudor Jones’s Halozyme HALO Stock Holding History

Paul Tudor Jones’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,200	Closed	-$659K	–	3854
2026 Q1	$659K	Buy	10,200 +7,000	+219%	+$493K	﹤0.01%	2645
2025 Q4	$215K	Buy	+3,200	New	+$215K	﹤0.01%	3257

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Paul Tudor Jones's HALO Position: Q4 2025 in Review

Paul Tudor Jones sold out of Halozyme (HALO) in Q4 2025, closing a stake of 61,683 shares — an estimated $4.15M sold.

Paul Tudor Jones first reported a position in HALO in Q3 2015 and held it in 9 quarters. The position peaked at $4.52M in Q3 2025. 618 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

Paul Tudor Jones reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
Paul Tudor Jones sold 61,683 Halozyme shares in Q4 2025, an estimated $4.15M.
Paul Tudor Jones first reported a position in Halozyme in Q3 2015 and held it in 9 quarters.
Paul Tudor Jones's Halozyme position peaked at $4.52M in Q3 2025.
618 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on Tudor Investment Corp's 13F filing for Q4 2025, filed 17 Feb 2026.